BD, Euro­clone to de­velop tests for ST in­fec­tions

BioSpectrum (Asia) - - Supplier News -

Bec­ton, Dick­in­son and Com­pany (BD) and Ital­ian di­ag­nos­tic prod­ucts maker Euro­clone Di­ag­nos­tica have en­tered an agree­ment for the devel­op­ment and global dis­tri­bu­tion of molec­u­lar tests to de­tect emerg­ing sex­u­ally trans­mit­ted pathogens. The molec­u­lar tests are ex­pected to im­prove the po­ten­tial for an ac­cu­rate di­ag­no­sis and treat­ment in the pres­ence or ab­sence of symp­toms. In ad­di­tion to sup­port­ing clin­i­cal lab­o­ra­to­ries for antimicrobial stew­ard­ship, the as­says will help in­sti­tu­tions to com­ply with Euro­pean guide­lines for sex­u­ally trans­mit­ted in­fec­tions (STI) screen­ing. The new as­says will run on the fully au­to­mated BD MAX Sys­tem to de­tect in­fec­tious gen­i­tal my­coplas­mas such as My­coplasma and Ureaplasma species that are dif­fi­cult to di­ag­nose us­ing stan­dard meth­ods. Lack of proper di­ag­no­sis and treat­ment of such in­fec­tions are re­ported to re­sult in im­me­di­ate and long-term health con­se­quences, in­clud­ing in­fer­til­ity and height­ened HIV sus­cep­ti­bil­ity.

Newspapers in English

Newspapers from India

© PressReader. All rights reserved.